Expert group confirms Armenia met hepatitis B control targets

The assessment considered vaccination coverage, prevention of transmission around birth and signs of infection among vaccinated groups.

The assessment considered vaccination coverage, prevention of transmission around birth and signs of infection among vaccinated groups.
Armenia has met regional targets for controlling hepatitis B through vaccination, the European Technical Advisory Group of Experts (ETAGE) has confirmed, according to an October 6 report by Armenpress. The validation concerns control through immunization, not elimination of the infection or guaranteed protection for every child.
ETAGE consists of immunization experts appointed by the World Health Organization’s regional director for Europe. The group provides independent review and technical advice to WHO’s European immunization programme.
The assessment considered high hepatitis B vaccination coverage, prevention of perinatal transmission—transmission around birth—and low prevalence of HBsAg among vaccinated groups. HBsAg, or hepatitis B surface antigen, is a marker of infection; prevalence describes how common that marker is within a group. The precise vaccination rates, HBsAg measurements and numerical thresholds used in Armenia’s assessment remain unspecified.
Roberta Pastore, WHO/Europe’s lead for immunization programme strengthening, said the validation confirmed two decades of successful efforts to introduce hepatitis B vaccination for all newborns and children and ensure high coverage. She described Armenia as moving closer to eliminating the disease, rather than having achieved elimination.
Stepan Atoyan, director general of Armenia’s National Center for Disease Control and Prevention, said acute hepatitis B—the short-term form of the disease—was no longer being recorded among children. His statement concerns recorded acute cases, not the absence of every hepatitis B infection.
Health Minister Anahit Avanesyan said vaccination and the wider immunization programme must continue to preserve and improve the gains. She also said support for medicines to manage chronic hepatitis B was under discussion, with pregnant women to be considered first and possible expansion later. That discussion was not an announcement of an adopted treatment entitlement.

A study explains why removing systematic drift makes climate assumptions account for more of the remaining uncertainty—and what that correction leaves out.
5 min

The commission’s October vote could advance new protected areas and tribal harvest rules, but approval and shared management remain unsettled.
4 min

An Eos comparison traces hillside failures into river channels and the bay after heavy rain in North Korea. Clouds and delayed access to imagery limit the initial assessment.
2 min